This promoted an investigation into the effects of fisetin on PI3K/AKT/mTOR and apoptosis pathway on colon cancer cell Caco-2, highlighting its significance as a target in CRC treatment. The gene discussed is AKT1; the disease is malignant colon neoplasm.